Ku, Elaine
- University of California, San Francisco · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #5,717
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2014 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$1.5M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#5,717
By linked amount among FY2023 PIs
Earliest Year Loaded
2014
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Ku, Elaine as a PI. Multi-PI records show the full award amount for context.
- 1U2CDK133488-01A1U2CContact PILearners to LeAders in benign Urology, benign Nephrology, and non-Cancer HematologyUniversity of California, San Francisco · Internal Medicine (NIH department code)$832.6Kaward amount
- 5R01DK121904-04R01Contact PIAcute declines in kidney function during blood pressure interventions in CKDUniversity of California, San Francisco · Internal Medicine (NIH department code)$679.6Kaward amount
Award organization
Organizations that administered FY2023 awards listing Ku, Elaine as a PI.
FY2023 award administered by University of California, San Francisco (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2014First NIH AwardUniversity of California, San Francisco
- 2018$500K Cumulative Funding
- 2018R01 Grant Holder
- 2020$1M Cumulative Funding
- 2022$2M Cumulative Funding
- 2023Entered Top 50% NationallyRanked #5717